Metabolic Disease

Cardiovascular and Metabolic Disease Research at Novartis

With new tools and approaches comes a broader opportunity to benefit patients. Cardiovascular and metabolic diseases are responsible for an estimated 18 million deaths worldwide each year and represent an enormous burden on individuals and society. Our cardiovascular and metabolic disease researchers are developing a diverse portfolio of approaches to prevent, delay or reverse these […]

Scroll to top